Insight

Aug 5, 2024, 10:25

5 papers about Lung Cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:

1. RBM10 mutation as a potential negative prognostic/predictive biomarker to therapy in non-small-cell lung cancer

Authors: Amanda Reyes, Michelle Afkhami, Erminia Massarelli, Jeremy Fricke, Isa Mambetsariev, Xiaochen Li, Giovanny Velasquez, Ravi Salgia

Stephen Liu

2. Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC

Authors: Filippo Tommaso Gallina, Vittoria Balzano, Nicla Porciello, Riccardo Tajè, Daniele Forcella, Enrico Melis, Fabiana Letizia Cecere, Francesca Fusco, Simonetta Buglioni, Paolo Visca, Paola Nisticò, Federico Cappuzzo, Jonathan Spicer

Stephen Liu

3. 1000 Robotic-assisted lobectomies for primary lung cancer: 16 years single center experience

Authors: Monica Casiraghi, Andrea Cara, Antonio Mazzella, Luca Bertolaccini, Patrick Maisonneuve, Lorenzo Spaggiari

Stephen Liu

4. Tarlatamab for Large-Cell Neuroendocrine Carcinoma in a Young Adult: A Case Report

Authors: Shetal Patel, Young Whang, Chaely Medley, Kevin Chen, Jasmine Jordan, Dante Bortone, Benjamin Vincent, Jared Weiss

Stephen Liu

5. Antibiotic use and survival in late-stage non-small cell lung cancer patients treated with chemo-immunotherapy

Authors: Emanuela Taioli, Raja Flores, Arwa Abdelhamid, Matthew Untalan, Tara Ivic-Pavlicic, Stephanie Tuminello

Stephen Liu

Follow Stephen Liu on X for more such content.

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.

Amanda Reyes Andrea Cara Antonio Mazzella Benjamin Vincent cancer Chaely Medley chemo-immunotherapy Dante Bortone drug development Emanuela Taioli Erminia Massarelli Federico Cappuzzo Filippo Tommaso Gallina Georgetown Lombardi Comprehensive Cancer Center Giovanny Velasquez IASLC International Association for the Study of Lung Cancer Isa Mambetsariev Jared Weiss Jasmine Jordan Jeremy Fricke Jonathan Spicer Kevin Chen Lorenzo Spaggiari Luca Bertolaccini Michelle Afkhami Monica Casiraghi NSCLC OncoDaily Oncology Paola Nisticò Patrick Maisonneuve PD-L1 Raja Flores RBM10 mutation Research Shetal Patel treatment Vittoria Balzano Xiaochen Li Young Whang

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage